| 6301 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
19 |
| 6302 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
68 |
| 6303 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6304 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6305 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia; Myeloproliferative Syndrome |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6306 |
Apheresis |
Autologous |
Amyloidosis |
Hematology |
2018 |
Standard Therapy |
Germany |
72 |
| 6307 |
Apheresis |
Autologous |
Amyloidosis |
Hematology |
2018 |
Standard Therapy |
Germany |
75 |
| 6308 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Germany |
61 |
| 6309 |
Apheresis |
Autologous |
Apoplexy |
Hematology |
2018 |
Standard Therapy |
Germany |
3 |
| 6310 |
Apheresis |
Allogeneic |
Atypical Chronic Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
58 |
| 6311 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
41 |
| 6312 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6313 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6314 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6315 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
52 |
| 6316 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
46 |
| 6317 |
Apheresis |
Allogeneic |
B-Cell Chronic Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6318 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
69 |
| 6319 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
43 |
| 6320 |
Apheresis |
Allogeneic |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6321 |
Apheresis |
Allogeneic |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
32 |
| 6322 |
Apheresis |
Allogeneic |
Blastic Nk Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6323 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
15 |
| 6324 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6325 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
49 |
| 6326 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
38 |
| 6327 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
63 |
| 6328 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
48 |
| 6329 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
25 |
| 6330 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
41 |
| 6331 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
44 |
| 6332 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
54 |
| 6333 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
39 |
| 6334 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
63 |
| 6335 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
56 |
| 6336 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
71 |
| 6337 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
51 |
| 6338 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6339 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6340 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
49 |
| 6341 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
60 |
| 6342 |
Apheresis |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
54 |
| 6343 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
71 |
| 6344 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma – Relapse |
Hematology |
2018 |
Standard Therapy |
Germany |
71 |
| 6345 |
Apheresis |
Allogeneic |
Fanconi Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
9 |
| 6346 |
Apheresis |
Allogeneic |
Follicular Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
44 |
| 6347 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6348 |
Apheresis |
Allogeneic |
Follicular Lymphoma (Non-Hodgkin Lymphoma) |
Hematology |
2018 |
Standard Therapy |
Poland |
56 |
| 6349 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2018 |
Standard Therapy |
Germany |
23 |
| 6350 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2018 |
Standard Therapy |
Germany |
31 |
| 6351 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
38 |
| 6352 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
27 |
| 6353 |
Apheresis |
Allogeneic |
Hypoplastic Mds-Eb2 With Incipient Saml |
Hematology |
2018 |
Standard Therapy |
Poland |
63 |
| 6354 |
Apheresis |
Autologous |
Large B-Cell Non-Hodgkin-Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6355 |
Apheresis |
Allogeneic |
Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6356 |
Apheresis |
Allogeneic |
Lymphomatoid Granulomatosis |
Hematology |
2018 |
Standard Therapy |
Germany |
36 |
| 6357 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6358 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
64 |
| 6359 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
44 |
| 6360 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6361 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6362 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2018 |
Standard Therapy |
Germany |
31 |
| 6363 |
Apheresis |
Allogeneic |
Morbus Hodgkin-Relapse |
Hematology |
2018 |
Standard Therapy |
Germany |
35 |
| 6364 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6365 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
61 |
| 6366 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
61 |
| 6367 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6368 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
57 |
| 6369 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
53 |
| 6370 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
57 |
| 6371 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6372 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
47 |
| 6373 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
60 |
| 6374 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6375 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6376 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6377 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6378 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
54 |
| 6379 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
58 |
| 6380 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
51 |
| 6381 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
69 |
| 6382 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6383 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6384 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6385 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6386 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6387 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
64 |
| 6388 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
63 |
| 6389 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
55 |
| 6390 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
60 |
| 6391 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
61 |
| 6392 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6393 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
64 |
| 6394 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
55 |
| 6395 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6396 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
64 |
| 6397 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6398 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
61 |
| 6399 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
69 |
| 6400 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
73 |